Hong Shik Yun
Overview
Explore the profile of Hong Shik Yun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
217
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kwon S, Chung E, Kc S, White A, Chung S, Horton J, et al.
Int J Radiat Oncol Biol Phys
. 2024 Dec;
121(5):1258-1270.
PMID: 39672516
Purpose: Interleukin-13 (IL-13) is a known mediator of radiation-induced lung injury (RILI). IL-13Rα2 has an accepted role in antagonizing IL-13 signaling by acting as a decoy receptor. We sought to...
2.
Yun H, Kramp T, Palanichamy K, Tofilon P, Camphausen K
Sci Rep
. 2024 May;
14(1):12363.
PMID: 38811596
Radiotherapy is the standard treatment for glioblastoma (GBM), but the overall survival rate for radiotherapy treated GBM patients is poor. The use of adjuvant and concomitant temozolomide (TMZ) improves the...
3.
Yun H, Lee J, Kim J, Sim Y, Lee C, Park J, et al.
Cancer Sci
. 2021 Oct;
113(1):145-155.
PMID: 34714604
To improve the poor survival rate of lung cancer patients, we investigated the role of HDGF-related protein 3 (HRP-3) as a potential biomarker for lung cancer. The expression of endogenous...
4.
Yun H, Lee J, Kil W, Kramp T, Tofilon P, Camphausen K
Mol Cancer Ther
. 2021 Jun;
20(9):1672-1679.
PMID: 34158343
AZD0530, a potent small-molecule inhibitor of the Src kinase family, is an anticancer drug used in the treatment of various cancers. In the case of glioblastoma (GBM), where resistance to...
5.
Baek J, Yun H, Kim J, Lee J, Lee Y, Lee C, et al.
Cell Death Dis
. 2020 May;
11(5):398.
PMID: 32457423
The poor therapeutic efficacy of non-small cell lung cancer (NSCLC) is partly attributed to the acquisition of chemoresistance. To investigate the mechanism underlying this resistance, we examined the potential link...
6.
Baek J, Yun H, Kwon G, Lee J, Kim J, Jo Y, et al.
Cell Death Dis
. 2019 Feb;
10(3):156.
PMID: 30770789
Current lung cancer treatments are far from satisfactory; thus, finding novel treatment targets is crucial. We recently identified procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (PLOD3), which is involved in fibrosis and tissue...
7.
Baek J, Yun H, Kwon G, Kim J, Lee C, Song J, et al.
Cell Death Dis
. 2018 Nov;
9(12):1138.
PMID: 30442941
Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (PLOD3), a membrane-bound homodimeric enzyme, hydroxylates lysyl residues in collagen-like peptides; however, its role in lung cancer is unknown. This study aimed to investigate the role of...
8.
Baek J, Lee J, Yun H, Lee C, Song J, Um H, et al.
Cell Death Dis
. 2018 May;
9(5):496.
PMID: 29717133
Kinesins act as molecular microtubule-dependent motor proteins and have various important cellular functions related to cell division, intracellular transport, and membrane trafficking. However, the function of kinesin light chain 4...
9.
Yun H, Baek J, Yim J, Um H, Park J, Song J, et al.
Cancer Biol Ther
. 2016 Feb;
17(2):208-18.
PMID: 26901847
Tumor cell radioresistance is a major contributor to radiotherapy failure, highlighting the importance of identifying predictive biomarkers for radioresistance. In this work, we established a radioresistant H460 (RR-H460) cell line...
10.
Yim J, Yun H, Lee S, Baek J, Lee C, Song J, et al.
Biochem Biophys Res Commun
. 2015 Nov;
469(1):94-100.
PMID: 26592665
The function of PSMC5 (proteasome 26S subunit, ATPase 5) in tumors, particularly with respect to cancer radioresistance, is not known. Here, we identified PSMC5 as a novel radiosensitivity biomarker, demonstrating...